Skip to main content
. Author manuscript; available in PMC: 2025 Aug 25.
Published in final edited form as: Arch Clin Biomed Res. 2025 Jun 30;9(4):304–315. doi: 10.26502/acbr.50170467

Table 1:

Sequences of forward and reverse oligonucleotides used for phenotypic characterization by RT-qPCR. 18S gene was used as a housekeeping gene to normalize results.

Phenotype marker Forward Reverse
P2RY12 5’-GTGATGCCAAACTGGGAACAGG-3’ 5’-CTGGTGGTCTTCTGGTAGCGAT-3’
CD68 5’-CTCCAAGCCCAGATTCAGATT-3’ 5’-GGGAATGAGAGAAGCAGGTG-3’
CD45 5’-GGTTTCAAAGAACCCAGGAAATAC-3’ 5’-ACATCGAGTGACCATGACAATAA-3’
CD86 5’-CCCAGAACCTAAGAAGATGAGTG-3’ 5’-GCTCGTAACATCAGGGAATGA-3’
CD32 5’-CTCTGGTCAAGGTCACATTCTT-3’ 5’-TTGGATGAGAACAGCGTGTAG-3’
CD206 5’-GGACGTGGCTGTGGATAAAT-3’ 5’-ACCCAGAAGACGCATGTAAAG-3’
CD163 5’-GTGTGATGACTCTTGGGACTT-3’ 5’-CCTGACCAAACTCTGCTTCT-3’
18S 5’-CCCACGGAATCGAGAAAGAG-3’ 5’-TTGACGGAAGGGCACCA-3’

CD: cluster of differentiation. General microglia markers: P2Y12: P2Y purinoceptor 12; CD68 or microsialin; CD45 or protein tyrosine phosphatase, receptor type, C (PTPRC). M1 phenotype: CD86 or T-lymphocyte activation antigen CD86; CD32 or low-affinity immunoglobulin gamma Fc region receptor II. M2 phenotype: CD206 or macrophage mannose receptor 1; CD163 or scavenger receptor cysteine-rich type 1 protein.